Gazzaniga A - Search Results

1

Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.

Melocchi A, Parietti F, Maroni A, Foppoli A, Gazzaniga A, Zema L. Melocchi A, et al. Among authors: gazzaniga a. Int J Pharm. 2016 Jul 25;509(1-2):255-263. doi: 10.1016/j.ijpharm.2016.05.036. Epub 2016 May 20. Int J Pharm. 2016. PMID: 27215535 Free article.

2

The use of beta-cyclodextrin as a pelletization agent in the extrusion/spheronization process.

Gazzaniga A, Sangalli ME, Bruni G, Zema L, Vecchio C, Giordano F. Gazzaniga A, et al. Drug Dev Ind Pharm. 1998 Sep;24(9):869-73. doi: 10.3109/03639049809088533. Drug Dev Ind Pharm. 1998. PMID: 9876539

3

Rotary tangential spray technique for aqueous film coating of indobufen pellets.

Vecchio C, Fabiani F, Sangalli ME, Zema L, Gazzaniga A. Vecchio C, et al. Among authors: gazzaniga a. Drug Dev Ind Pharm. 1998 Mar;24(3):269-74. doi: 10.3109/03639049809085619. Drug Dev Ind Pharm. 1998. PMID: 9876584

4

In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology).

Sangalli ME, Maroni A, Busetti C, Zema L, Giordano F, Gazzaniga A. Sangalli ME, et al. Among authors: gazzaniga a. Boll Chim Farm. 1999 Mar;138(3):68-73. Boll Chim Farm. 1999. PMID: 10394705 Clinical Trial.

5

In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery.

Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. Sangalli ME, et al. Among authors: gazzaniga a. J Control Release. 2001 May 18;73(1):103-10. doi: 10.1016/s0168-3659(01)00291-7. J Control Release. 2001. PMID: 11337063 Clinical Trial.

6

Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide.

Bettini R, Bonassi L, Castoro V, Rossi A, Zema L, Gazzaniga A, Giordano F. Bettini R, et al. Among authors: gazzaniga a. Eur J Pharm Sci. 2001 Jun;13(3):281-6. doi: 10.1016/s0928-0987(01)00115-4. Eur J Pharm Sci. 2001. PMID: 11384850

7

Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices.

Sangalli ME, Zema L, Maroni A, Foppoli A, Giordano F, Gazzaniga A. Sangalli ME, et al. Among authors: gazzaniga a. Biomaterials. 2001 Oct;22(19):2647-51. doi: 10.1016/s0142-9612(01)00005-9. Biomaterials. 2001. PMID: 11519784

8

A study on the release mechanism of drugs from hydrophilic partially coated perforated matrices.

Sangalli ME, Maroni A, Zema L, Cerea M, Conte U, Gazzaniga A. Sangalli ME, et al. Among authors: gazzaniga a. Farmaco. 2003 Sep;58(9):971-6. doi: 10.1016/S0014-827X(03)00168-X. Farmaco. 2003. PMID: 13679193

9

Polymorphism of NCX4016, an NO-releasing derivative of acetylsalicylic acid.

Foppoli A, Sangalli ME, Maroni A, Gazzaniga A, Caira MR, Giordano F. Foppoli A, et al. Among authors: gazzaniga a. J Pharm Sci. 2004 Mar;93(3):521-31. doi: 10.1002/jps.10547. J Pharm Sci. 2004. PMID: 14762891

10

Modeling of drug release from partially coated matrices made of a high viscosity HPMC.

Grassi M, Zema L, Sangalli ME, Maroni A, Giordano F, Gazzaniga A. Grassi M, et al. Among authors: gazzaniga a. Int J Pharm. 2004 May 19;276(1-2):107-14. doi: 10.1016/j.ijpharm.2004.02.016. Int J Pharm. 2004. PMID: 15113619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters